Multi-drug delivery to tumor cells via micellar nanocarriers

International Journal of Pharmaceutics

Volumn 419, Issue 1-2, 2011, Pages 281-286

  Katragadda, Usha ^a   Teng, Quincy ^a   Rayaprolu, Bindhu Madhavi ^a   Chandran, Thripthy ^a   Tan, Chalet ^a  

^a MERCER UNIVERSITY   (United States)

Author keywords

17 AAG; Combination therapy; Paclitaxel; PEG DSPE; PEG PLA; Polymeric micelles

Indexed keywords

DISTEAROYLPHOSPHATIDYLETHANOLAMINE TOCOPHERYL POLYETHYLENE GLYCOL 1000; LACTIC ACID; MACROGOL 10000; NANOCARRIER; PACLITAXEL; TANESPIMYCIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; DRUG STABILITY; FEMALE; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MICELLE; OVARY CANCER; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BENZOQUINONES; CELL LINE, TUMOR; CELL PROLIFERATION; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG COMBINATIONS; DRUG DELIVERY SYSTEMS; FEMALE; HALF-LIFE; HUMANS; LACTAMS, MACROCYCLIC; MICELLES; NANOPARTICLES; OVARIAN NEOPLASMS; PACLITAXEL; PHOSPHATIDYLETHANOLAMINES; POLYETHYLENE GLYCOLS; VITAMIN E;

EID: 80053572463     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.07.033     Document Type: Article

References (22)

1. T. Chandran, U. Katragadda, Q. Teng, and C. Tan Design and evaluation of micellar nanocarriers for 17-allylamino-17-demethoxygeldanamycin (17-AAG) Int. J. Pharm. 392 2010 170 177
2. H. Chen, S. Kim, W. He, H. Wang, P.S. Low, K. Park, and J.X. Cheng Fast release of lipophilic agents from circulating PEG-PDLLA micelles revealed by in vivo Förster resonance energy transfer imaging Langmuir 24 2008 5213 5217
3. M.E. Davis, Z. Chen, and D.M. Shin Nanoparticle therapeutics: an emerging treatment modality for cancer Nat. Rev. Drug Discov. 7 2008 771 782
4. W. Dean-Colomb, and F.J. Esteva Emerging agents in the treatment of anthracycline- and taxane-refractory metastatic breast cancer Semin. Oncol. 35 2008 S31 S38
5. T.A. Diezi, Y. Bae, and G.S. Kwon Enhanced stability of PEG-block-poly(N-hexyl stearate l-aspartamide) micelles in the presence of serum proteins Mol. Pharm. 7 2010 1355 1360
6. M.J. Egorin, E.G. Zuhowski, D.M. Rosen, D.L. Sentz, J.M. Covey, and J.J. Eiseman Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17- demethoxygeldanamycin (NSC 330507) in CD2F1 mice Cancer Chemother. Pharmacol. 47 2001 291 302 (Pubitemid 32640768)
7. D.-W. Kim, S.-Y. Kim, H.-K. Kim, S.-W. Kim, S.W. Shin, J.S. Kim, K. Park, M.Y. Lee, and D.S. Heo Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer Ann. Oncol. 18 2007 2009 2014 (Pubitemid 350286241)
8. T.-Y. Kim, D.-W. Kim, J.-Y. Chung, A.G. Shin, S.-C. Kim, D.S. Heo, N.K. Kim, and Y.-J. Bang Phase I and pharmacokinetic study of Genexol-PM, a Cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies Clin. Cancer Res. 10 2004 3708 3716 (Pubitemid 38697604)
9. A.N. Lukyanov, Z. Gao, L. Mazzola, and V.P. Torchilin Polyethylene glycol-diacyllipid micelles demonstrate increased accumulation in subcutaneous tumors in mice Pharm. Res. 19 2002 1424 1429 (Pubitemid 35266545)
10. Y. Matsumura Poly(amino acid) micelles nanocarriers in preclinical and clinical studies Adv. Drug Deliv. Rev. 60 2008 899 914
11. S. Modi, A.T. Stopeck, M.S. Gordon, D. Mendelson, D.B. Solit, R. Bagatell, W. Ma, J. Wheler, N. Rosen, L. Norton, G.F. Cropp, R.G. Johnson, A.L. Hannah, and C.A. Hudis Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2-overexpressing breast cancer: a phase I dose-escalation study J. Clin. Oncol. 25 2007 5410 5417 (Pubitemid 350232217)
12. N. Nishiyama, and K. Kataoka Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery Pharmacol. Ther. 112 2006 630 648 (Pubitemid 44592613)
13. S.S. Ramalingan, M.J. Egorin, R.K. Ramanathan, S.C. Remick, R.P. Sikorski, T.F. Lagattuta, G.S. Chatta, D.M. Friedland, R.G. Stoller, D.M. Potter, S.P. Ivy, and C.P. Belani A phase I study of 17-allylamino-17- demethoxygeldanamycin combined with paclitaxel in patients with advanced solid malignancies Clin. Cancer Res. 14 2008 3456 3461
14. P.G. Richardson, A.A. Chanan-Khan, M. Alsina, M. Albitar, D. Berman, M. Messina, C.S. Mitsiades, and K.C. Anderson Tanespimycin monotherapy in relapsed multiple myeloma: results of a phase 1 dose-escalation study Br. J. Haematol. 150 2010 438 445
15. M.M. Roforth, and C. Tan Combination of rapamycin and 17-allylamino-17-demethoxygeldanamycin abrogates Akt activation and potentiates mTOR blockade in breast cancer cells Anticancer Drugs 19 2008 681 688
16. M.W. Saif, N.A. Podoltsev, M.S. Rubin, J.A. Figueroa, M.Y. Lee, J. Kwon, E. Rowen, J. Yu, and R.O. Kerr Phase II clinical trial of paclitaxel loaded polymeric micelle in patients with advanced pancreatic cancer Cancer Invest. 28 2010 186 194
17. N. Sain, B. Krishnan, M.G. Ormerod, A. De Rienzo, W.M. Liu, S.B. Kaye, P. Workman, and A.L. Jackman Potentiation of paclitaxel activity by the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin in human ovarian carcinoma cell lines with high levels of activated AKT Mol. Cancer Ther. 5 2006 1197 1208 (Pubitemid 43881312)
18. A. Sawai, S. Chandarlapaty, H. Greulich, M. Gonen, Q. Ye, C.L. Arteaga, W. Sellers, N. Rosen, and D.B. Solit Inhibition of Hsp90 down-regulates mutant epidermal growth factor receptor (EGFR) expression and sensitizes EGFR mutant tumors to paclitaxel Cancer Res. 68 2008 589 596 (Pubitemid 351380088)
19. H.-C. Shin, A.W.G. Alani, D.A. Rao, N.C. Rockich, and G.S. Kwon Multi-drug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drug J. Control. Release 14 2009 294 300
20. D.B. Solit, A.D. Basso, A.B. Olshen, H.I. Scher, and N. Rosen Inhibition of heat shock protein 90 function down-regulates Akt kinase and sensitizes tumors to taxol Cancer Res. 63 2003 2139 2144 (Pubitemid 36538618)
21. J. Trepel, M. Mollapour, G. Giaccone, and L. Neckers Targeting the dynamic HSP90 complex in cancer Nat. Rev. Cancer 10 2010 537 549
22. A.N. Tse, D.S. Klimstra, M. Gonen, M. Shah, T. Sheikh, R. Sikorski, R. Carvajal, J. Mui, C. Tipian, E. O'Reilly, K. Chung, R. Maki, R. Lefkowitz, K. Brown, K. Manova-Todorova, N. Wu, M.J. Egorin, D. Kelsen, and G.K. Schwartz A phase I dose-escalation study of irinotecan in combination with 17-allylamino-17-demethoxygeldanamycin in patients with solid tumors Clin. Cancer Res. 14 2008 6704 6711